Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("ARNING M")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 23 of 23

  • Page / 1

Export

Selection :

  • and

Insert moulding : Automatic manufacturing of rubber-to-metal and rubber-to-plastic moulded componentsARNING, M.Polymers & polymer composites. 1997, Vol 5, Num 8, pp 589-597, issn 0967-3911Conference Paper

KOLLOIDCHEMISCHE EIGENSCHAFTEN, VERTEILUNGS- UND BINDUNGSVERHALTEN VON PHENOTHIAZINDERIVATEN. II. EINFLUSS VON CHEMISCHER STRUKTUR UND MILIEUBEDINGUNGEN AUF DIE MIZELLGEWICHTE. = PROPRIETE COLLOIDALE, DE PARTAGE ET DE LIAISON DES DERIVES DE LA PHENOTHIAZINE. II. INFLUENCE DE LA STRUCTURE CHIMIQUE ET DES CONDITIONS AMBIANTES SUR LE POIDS DES MICELLESTHOMA K; ARNING M.1976; ARCH. PHARM.; DTSCH.; DA. 1976; VOL. 309; NO 10; PP. 851-861; ABS. ANGL.; BIBL. 20 REF.Article

DER EINFLUSS HYDROTROPER SUBSTANZEN AUF DIE ASSOZIATIONSEIGENSCHAFTEN VON THIORIDAZIN. = INFLUENCE DES SUBSTANCES HYDROTROPES SUR LES PROPRIETES D'ASSOCIATION DE THIORIDAZINETHOMA K; ARNING M.1976; ARCH. PHARM.; DTSCH.; DA. 1976; VOL. 309; NO 11; PP. 865-872; ABS. ANGL.; BIBL. 10 REF.Article

KOLLOIDCHEMISCHE EIGENSCHAFTEN, VERTEILUNGS- UND BILDUNGS-VERHALTEN VON PHENOTHIAZINDERIVATEN. V. BEZIEHUNGEN ZWISCHEN EIWEISSBINDUNG UND PHYSIKALISCH-CHEMISCHEN EIGENSCHAFTEN. = PROPRIETES COLLOIDALES, DE PARTAGE ET DE LIAISON DES DERIVES DE LA PHENOTHIAZINE. V. RELATION ENTRE LA LIAISON A L'OVALBUMINE ET LES PROPRIETES PHYSICOCHIMIQUESTHOMA K; ARNING M.1976; ARCH. PHARM.; DTSCH.; DA. 1976; VOL. 309; NO 12; PP. 945-959; ABS. ANGL.; BIBL. 28 REF.Article

KOLLOIDCHEMISCHE EIGENSCHAFTEN, VERTEILUNGS- UND BINDUNGSVERHALTEN VON PHENOTHIAZINDERIVATEN. IV. BEZIEHUNGEN ZWISCHEN VERTEILUNGSKOEFFIZIENTEN UND ASSOZIATIONS-EIGENSCHAFTEN. = PROPRIETES COLLOIDALES, DE PARTAGE, ET PROPRIETES D'ASSOCIATION DES DERIVES DE PHENOTHIAZINE. IV. RELATIONS ENTRE LES COEFFICIENTS DE PARTAGE ET LES PROPRIETES D'ASSOCIATIONTHOMA K; ARNING M.1976; ARCH. PHARM.; DTSCH.; DA. 1976; VOL. 309; NO 11; PP. 872-881; ABS. ANGL.; BIBL. 13 REF.Article

KOLLOIDCHEMISCHE EIGENSCHAFTEN, VERTEILUNGS- UND BINDUNGSVERHALTEN VON PHENOTHIAZINDERIVATEN. I. BEZIEHUNGEN ZWISCHEN DER CHEMISCHEN STRUKTUR UND DEN ASSOZIATIONS-EIGENSCHAFTEN. = PROPRIETES COLLOIDALES, DE PARTAGE ET DE LIAISON DES DERIVES DE LA PHENOTHIAZINE. I. RELATIONS ENTRE LA STRUCTURE CHIMIQUE ET LES PROPRIETES D'ASSOCIATIONTHOMA K; ARNING M.1976; ARCH. PHARM.; DTSCH.; DA. 1976; VOL. 309; NO 10; PP. 837-850; ABS. ANGL.; BIBL. 18 REF.Article

Serum erythropoietin concentrations in patients with myelodysplastic syndromesAUL, C; ARNING, M; RUNDE, V et al.Leukemia research. 1991, Vol 15, Num 7, pp 571-575, issn 0145-2126Article

Modeling long-term compost application effects on nitrate leachingGERKE, H. H; ARNING, M; STÖPPLER-ZIMMER, H et al.Plant and soil. 1999, Vol 213, Num 1-2, pp 75-92, issn 0032-079XConference Paper

Septicemia due to Streptococcus mitis in neutropenic patients with acute leukemiaARNING, M; GEHRT, A; AUL, C et al.Blut. 1990, Vol 61, Num 6, pp 364-368, issn 0006-5242, 5 p.Article

Preliminary results of treatment with itraconazole in patients with systemic fungal infectionsWOLF, H.-H; SCHARF, R. E; ARNING, M et al.Haematology and blood transfusion. 1990, Vol 33, pp 560-562, issn 0171-7111Article

Pulmonary toxicity during infusion of liposomal amphotericin B in two patients with acute leukemiaARNING, M; HEER-SONDERHOFF, A. H; WEHMEIER, A et al.European journal of clinical microbiology & infectious diseases (Print). 1995, Vol 14, Num 1, pp 41-43, issn 0934-9723Article

A review of hemolytic uremic syndrome in patients treated with gemcitabine therapyFUNG, M. C; STORNIOLO, A. M; NGUYEN, B et al.Cancer. 1999, Vol 85, Num 9, pp 2023-2032, issn 0008-543XArticle

Neutrophilic dermal infiltrates in granulocytopenic patients with acute leukemiaHEER-SONDERHOFF, A. H; ARNING, M; WEHMEIER, A et al.Annals of hematology (Print). 1995, Vol 71, Num 5, pp 257-261, issn 0939-5555Article

Infection prophylaxis in neutropenic patients with acute leukaemia : a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole/colistinARNING, M; WOLF, H. H; AUL, C et al.Journal of antimicrobial chemotherapy (Print). 1990, Vol 26, pp 137-142, issn 0305-7453, 6 p., SUPDArticle

Monitoring of multiple myeloma patients by simultaneously measuring marker substances of bone resorption and formationWITHOLD, W; ARNING, M; SCHWARZ, M et al.Clinica chimica acta. 1998, Vol 269, Num 1, pp 21-30, issn 0009-8981Article

Increases of sICAM-1 during neutropenic pneumonia in leukemic patientsSÜDHOFF, T; WEHMEIER, A; ARNING, M et al.Leukemia. 1997, Vol 11, Num 3, pp 346-351, issn 0887-6924Article

Infusion-related toxicity of three different amphotericin B formulations and its relations to cytokine plasma levels = Infusions-assoziierte Toxizität dreier Amphotericin B-Formulierungen und ihre Beziehung zu Zytokin-PlasmaspiegelnARNING, M; KLICHE, K. O; HEER-SONDERHOFF, A. H et al.Mycoses. 1995, Vol 38, Num 11-12, pp 459-465, issn 0933-7407Article

Granulocyte colony-stimulating factor (G-CSF) treatment in a neutropenic leukeumia patient with diffuse intestitial pulmonary infiltratesHEYLL, A; AUL, C; GOGOLIN, F et al.Annals of hematology (Print). 1991, Vol 63, Num 6, pp 328-332, issn 0939-5555Article

Prophylactic strategies to meet infectious complications in fludarabine-treated CLLSÜDHOFF, T; ARNING, M; SCHNEIDER, W et al.Leukemia. 1997, Vol 11, pp S38-S41, issn 0887-6924, SUP2Conference Paper

Gemcitabine plus dose-escalated epirubicin in advanced breast cancer : results of a phase I studyLÜFTNER, D; FLATH, B; AKRIVAKIS, C et al.Investigational new drugs. 1998, Vol 16, Num 2, pp 141-146, issn 0167-6997Article

Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancerHEINEMANN, V; WILKE, H; MERGENTHALER, H.-G et al.Annals of oncology. 2000, Vol 11, Num 11, pp 1399-1403, issn 0923-7534Article

A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancerOETTLE, H; RICHARDS, D; KINDLER, H. L et al.Annals of oncology. 2005, Vol 16, Num 10, pp 1639-1645, issn 0923-7534, 7 p.Article

A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancerOETTLE, H; ARNING, M; KORSTEN, F. W et al.Annals of oncology. 2000, Vol 11, Num 10, pp 1267-1272, issn 0923-7534Article

  • Page / 1